Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The most reliable path to coverage is a diagnosis of type 2 diabetes, which is the FDA-approved indication for several GLP-1 medications
It enhances insulin secretion in response to high blood sugar levels, slows down gastric emptying, and reduces the production of glucose in the liver
The information provided is for educational purposes relating to published scientific literature only
The risk of thyroid cancer, specifically medullary thyroid carcinoma, has been noted, and as such, Wegovy product manufacturers addressed safety warning against use in individuals with a personal or family history of multiple endocrine neoplasia syndrome type 2
US$ 28.36
US$ 26.85
US$ 28.97
